Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin

Deitelzweig, Steven, Gupta, Kiran, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Eaddy, Michael and Squibb, Bristol-Myers (2016). Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin. In: 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, (876-876). April 02-04, 2016. doi:10.1016/S0735-1097(16)30877-4


Author Deitelzweig, Steven
Gupta, Kiran
Ogbonnaya, Augustina
Shah, Manan
Farrelly, Eileen
Lokhandwala, Tasneem
Eaddy, Michael
Squibb, Bristol-Myers
Title of paper Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin
Conference name 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC)
Conference location Chicago, United States
Conference dates April 02-04, 2016
Journal name Journal of the American College of Cardiology   Check publisher's open access policy
Place of Publication San Diego, United States
Publisher Elsevier
Publication Year 2016
Year available 2016
Sub-type Published abstract
DOI 10.1016/S0735-1097(16)30877-4
Open Access Status Not Open Access
ISSN 0735-1097
1558-3597
Volume 67
Issue 13
Start page 876
End page 876
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Fri, 05 Aug 2016, 19:45:39 EST by System User on behalf of Learning and Research Services (UQ Library)